-
Good news. I've spent too long playing around in Excel and failing to find a good way to model/ forecast the Exponential curve of the UK's vaccine programme.
The second dose totals tally closely to the first dose totals from ~11 weeks ago, as expected. So if you want to predict the number of "fully vaccinated" on a given date just look at the first dose total from 11 weeks before.
How can we be providing a less efficient roll-out than the privatised, failed HC system of the US?
The UK rollout is supply constrained. The distribution seems fine, or at least adequate for the volume of supply we have to distribute.
-
The UK rollout is supply constrained. The distribution seems fine, or at least adequate for the volume of supply we have to distribute.
All programs are subject to similar constraints.
Re 11 weeks. It works up until a point- that point is the interesting part. If your point of supply is as big a factor as you think, then we cannot expand to cover effectively.
If we can, and my assumptions so far have been that the people in charge have factored that into it.
In general- a see my posts previously- I have huge amounts of faith in a system I work in. I just don’t think we’re where the public thinks we are, and this is a problem.
Further, our reopening up has been predicated on first dose number, with predominant mixing in non-vaccinated age groups. This leads to a good assumption that before we get a chance to roll out vaccines to that age range, we will repeat a spike of spread.
Good news. I've spent too long playing around in Excel and failing to find a good way to model/ forecast the Exponential curve of the UK's vaccine programme.
I suspect I might need some more statistically minded people, and I need to go to work.
(/million)
@Fox
I hypothesised that earlier. However it is the jingoism that is irking me. How can we be providing a less efficient roll-out than the privatised, failed HC system of the US?
So yes- the effort individually is incredible, but nationwide must be rife with inefficiency.